Gerresheimer revenues increase 13 percent

qiangzi

Gerresheimer revenues increase 13 percent
% o8 T! a. O' L5 o) E; D1 t
$ j8 m: ?& ^  L" ~* SFriday, April 13, 2012

Dusseldorf, Germany - Gerresheimer AG, one of the leading worldwide partners of the pharma and healthcare industry, achieved strong growth in revenues in the first quarter of the financial year 2012. “We’ve got off to a very good start and are able to report excellent growth in revenues. Global demand for pharmaceutical packaging and products for the safe and reliable administration of medications is very high,“ said Uwe Rohrhoff, chief executive officer of Gerresheimer AG. Gerresheimer has experienced particularly strong growth in revenues in the first quarter of the 2012 financial year (December 1, 2011, to November 30, 2012). Its revenues increased by 13.6 percent to EUR 268.8 million. Currency effects had no impact on revenues. Core business operations, comprising pharmaceutical primary packaging products and medical devices made of glass and plastic, made an important contribution to this growth. However, the cosmetics and laboratory glass businesses also had a positive start to the year. Gerresheimer’s adjusted EBITDA was EUR 44.3 million in the first quarter of 2012, which is 6.2 percent higher than the prior year figure. The adjusted EBITDA margin was 16.5 percent in the first quarter of 2012, which is down from 17.7 percent in the prior year’s first quarter. Net income of EUR 6.8 million is slightly below the prior year’s EUR 7.1 million. Earnings per share were EUR 0.16 (prior year: EUR 0.20). Adjusted earnings per share have increased by EUR 0.02 to EUR 0.32 compared with the same prior year quarter.